Michael Heschel

Title: Michael Heschel: Innovator in Pharmaceutical Formulations

Introduction

Michael Heschel is a notable inventor based in Pirna, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral dosage forms. His innovative work focuses on enhancing the delivery and effectiveness of active ingredients in medication.

Latest Patents

Michael Heschel holds a patent for an oral dosage form for propiverine or its pharmaceutically acceptable salts with an extended release of the active ingredient. This patent describes the production of oral pharmaceutical compositions containing propiverine in amounts ranging from 4 mg to 60 mg. The formulations are designed to provide a prolonged release of the active agent, utilizing a blend of the active ingredient and one or more acidic substances with a pK value of less than 6.65. These compositions are either coated with a retarding layer or embedded in a matrix that may also be coated with additional retarding layers.

Career Highlights

Michael Heschel is associated with Apogepha Arzneimittel GmbH, where he applies his expertise in pharmaceutical formulations. His work has contributed to advancements in the delivery systems of medications, improving patient outcomes through innovative drug design.

Collaborations

Michael has collaborated with notable colleagues such as Thomas Gramatte and Peter Gruber. Their combined efforts in research and development have furthered the field of pharmaceutical sciences.

Conclusion

Michael Heschel's contributions to the pharmaceutical industry exemplify the importance of innovation in drug formulation. His patent for an extended-release oral dosage form highlights his commitment to improving medication delivery systems.